Concepedia

R L Cavanagh

RL

9

Publications

433

Citations

9

H-Index

1959

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

R L Cavanagh is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1959–1989

9

Publications

9

The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.

Anthony W. Pircio, Jonas A. Gylys, R L Cavanagh et al. · PubMed · 1976 · 144 citations

, , +13

Synthesis and biological activity of 3-substituted imidazo[1,2-a]pyridines as antiulcer agents

John E. Starrett, Thomas A. Montzka, Alfred R. Crosswell et al. · Journal of Medicinal Chemistry · 1989 · 97 citations

, , +13

Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog.

John E. Schurig, R L Cavanagh, J P Buyniski · PubMed · 1978 · 45 citations

, , +18

A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.

R L Cavanagh, J J Usakewicz, J P Buyniski · Journal of Pharmacology and Experimental Therapeutics · 1983 · 41 citations

Antitussive properties of butorphanol.

R L Cavanagh, Jonas A. Gylys, M. E. Bierwagen · PubMed · 1976 · 33 citations

, , +11

Rows per page

1–5 of 9